Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.
Cancer Invest
; 39(4): 315-320, 2021 Apr.
Article
in English
| MEDLINE | ID: covidwho-1132232
ABSTRACT
Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24-69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6-41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20-62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Sarcoma
/
Soft Tissue Neoplasms
/
SARS-CoV-2
/
COVID-19
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Language:
English
Journal:
Cancer Invest
Year:
2021
Document Type:
Article
Affiliation country:
07357907.2021.1903914
Similar
MEDLINE
...
LILACS
LIS